Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,575 | 58 | 94.0% |
| Education | $99.99 | 1 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $219.96 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $212.30 | 9 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $135.40 | 2 | $0 (2018) |
| AbbVie, Inc. | $125.88 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $122.81 | 3 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $113.99 | 2 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $106.80 | 1 | $0 (2019) |
| Lilly USA, LLC | $100.15 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $97.59 | 2 | $0 (2018) |
| Shire North American Group Inc | $81.54 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.81 | 1 | Novo Nordisk Inc ($17.81) |
| 2023 | $38.29 | 2 | Novo Nordisk Inc ($19.75) |
| 2022 | $69.11 | 4 | AstraZeneca Pharmaceuticals LP ($27.34) |
| 2019 | $106.80 | 1 | Teva Pharmaceuticals USA, Inc. ($106.80) |
| 2018 | $1,006 | 37 | Novo Nordisk Inc ($164.37) |
| 2017 | $436.20 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($116.69) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Diabetes | ||||||
| 10/03/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/27/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: PRIMARY CARE | ||||||
| 10/25/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 03/22/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $106.80 | General |
| Category: Central Nervous System | ||||||
| 09/11/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $97.65 | General |
| Category: DIABETES | ||||||
| 08/09/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $104.65 | General |
| Category: Obesity | ||||||
| 07/24/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: DIABETES | ||||||
| 07/23/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, JANUMET XR | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/03/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: DIABETES | ||||||
| 06/22/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET XR, STEGLATRO | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/18/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Diabetes | ||||||
| 06/12/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Neuroscience | ||||||
| 06/11/2018 | BOSTON SCIENTIFIC CORPORATION | SPECTRA WAVEWRITER (Device) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/06/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: DIABETES | ||||||
| 05/29/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: UROLOGY | ||||||
| 05/25/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/07/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 14 | $2,618 | $833.37 |
| 2022 | 6 | 102 | 120 | $17,266 | $6,555 |
| 2021 | 4 | 74 | 103 | $15,080 | $6,326 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $2,618 | $833.37 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $4,410 | $2,307 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 27 | $6,639 | $1,779 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 24 | $3,850 | $1,185 | 30.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 12 | 12 | $1,205 | $843.00 | 70.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $728.00 | $364.52 | 50.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 19 | 26 | $434.00 | $76.89 | 17.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 28 | $6,524 | $2,422 | 37.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $3,920 | $2,086 | 53.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 26 | $4,108 | $1,719 | 41.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 24 | 33 | $528.00 | $99.00 | 18.8% |
About Dr. Mishal Bhatt, M.D
Dr. Mishal Bhatt, M.D is a Family Medicine healthcare provider based in Matthews, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1760802045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mishal Bhatt, M.D has received a total of $1,675 in payments from pharmaceutical and medical device companies, with $17.81 received in 2024. These payments were reported across 59 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,575).
As a Medicare-enrolled provider, Bhatt has provided services to 188 Medicare beneficiaries, totaling 237 services with total Medicare billing of $13,715. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Matthews, NC
- Active Since 04/24/2014
- Last Updated 01/09/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760802045
Products in Payments
- JARDIANCE (Drug) $196.99
- INVOKANA (Drug) $135.40
- Androgel (Drug) $125.88
- TOUJEO (Drug) $113.99
- AJOVY (Drug) $106.80
- Saxenda (Drug) $104.65
- TRULICITY (Drug) $100.15
- XOLAIR (Biological) $83.99
- MYDAYIS (Drug) $81.54
- XIFAXAN (Drug) $72.84
- FARXIGA (Drug) $69.17
- Victoza (Drug) $59.72
- JANUVIA (Drug) $48.20
- Repatha (Biological) $39.81
- Rybelsus (Drug) $35.84
- NURTEC ODT (Drug) $23.74
- SPECTRA WAVEWRITER (Device) $23.11
- MYRBETRIQ (Drug) $22.82
- Prolia (Biological) $20.25
- Ozempic (Drug) $19.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Matthews
Gautam Patel, Md, MD
Family Medicine — Payments: $9,977
Dr. William Conner, Md, MD
Family Medicine — Payments: $5,349
Dr. Beth Carlson, M.d, M.D
Family Medicine — Payments: $3,387
Dr. Pasquale Baratta, Md, MD
Family Medicine — Payments: $2,578
Dr. Dixon Dehority, Md, MD
Family Medicine — Payments: $1,024
Dr. Tejal Patel, Md, MD
Family Medicine — Payments: $598.16